Document Detail

High frequency of the erythroid silent Duffy antigen genotype and lack of Plasmodium vivax infections in Haiti.
Jump to Full Text
MedLine Citation:
PMID:  23347639     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Malaria is a significant public health concern in Haiti where approximately 30,000 cases are reported annually with CDC estimates as high as 200,000. Malaria infections in Haiti are caused almost exclusively by Plasmodium falciparum, while a small number of Plasmodium malariae and an even smaller number of putative Plasmodium vivax infections have been reported. The lack of confirmed P. vivax infections in Haiti could be due to the genetic background of native Haitians. Having descended from West African populations, many Haitians could be Duffy negative due to a single nucleotide polymorphism from thymine to cytosine in the GATA box of the promoter region of the Duffy antigen receptor for chemokines (DARC) gene. This mutation, encoded by the FYES allele, eliminates the expression of the Duffy antigen on erythrocytes, which reduces invasion by P. vivax. This study investigated the frequency of the FYES allele and P. vivax infections in malaria patients with the goal of uncovering factors for the lack of P. vivax infections reported in Haiti.
METHODS: DNA was extracted from dried blood spots collected from malaria patients at four clinic locations in Haiti. The samples were analysed by polymerase chain reaction (PCR) for the presence of the P. vivax small subunit ribosomal RNA gene. PCR, sequencing, and restriction enzyme digestion were used to detect the presence of the FYES allele. Matched samples were examined for both presence of P. vivax and the FYES allele.
RESULTS: No cases of P. vivax were detected in any of the samples (0/136). Of all samples tested for the FYES allele, 99.4% had the FYES allele (163/164). Of the matched samples, 99% had the FYES allele (98/99).
CONCLUSIONS: In this preliminary study, no cases of P. vivax were confirmed by PCR and 99% of the malaria patients tested carried the FYES allele. The high frequency of the FYES allele that silences erythroid expression of the Duffy antigen offers a biologically plausible explanation for the lack of P. vivax infections observed. These results provide insights on the host susceptibility for P. vivax infections that has never before been investigated in Haiti.
Thomas A Weppelmann; Tamar E Carter; Zhongsheng Chen; Michael E von Fricken; Yves S Victor; Alexander Existe; Bernard A Okech
Related Documents :
9233749 - Arginine, glutamine, and dehydroepiandrosterone reverse the immunosuppressive effect of...
7148889 - Scarlet fever, toxic-shock syndrome and the staphylococcus.
12905139 - The epidemiology of burn wound infections: then and now.
3279219 - Eradication of candida burn wound septicemia in massively burned patients.
22214329 - Wolbachia and its implications for the immunopathology of filariasis.
6779699 - Topical and systemic antimicrobial agents in burns.
378589 - Enhancement of local immune response in the treatment of experimental peritonitis.
18642109 - Aspergillus to zygomycetes: causes, risk factors, prevention, and treatment of invasive...
24475559 - Antibacterial resistance: an overview.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2013-01-24
Journal Detail:
Title:  Malaria journal     Volume:  12     ISSN:  1475-2875     ISO Abbreviation:  Malar. J.     Publication Date:  2013  
Date Detail:
Created Date:  2013-03-18     Completed Date:  2013-06-24     Revised Date:  2013-07-11    
Medline Journal Info:
Nlm Unique ID:  101139802     Medline TA:  Malar J     Country:  England    
Other Details:
Languages:  eng     Pagination:  30     Citation Subset:  IM    
Department of Environmental and Global Health, University of Florida, PO Box 100188, Gainesville, FL 32610, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Disease Resistance*
Duffy Blood-Group System / genetics*
Gene Frequency
Malaria, Vivax / genetics*
Polymerase Chain Reaction
Polymorphism, Restriction Fragment Length
Polymorphism, Single Nucleotide
Promoter Regions, Genetic
Receptors, Cell Surface / genetics*
Sequence Analysis, DNA
Reg. No./Substance:
0/DARC protein, human; 0/Duffy Blood-Group System; 0/Receptors, Cell Surface

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Malar J
Journal ID (iso-abbrev): Malar. J
ISSN: 1475-2875
Publisher: BioMed Central
Article Information
Download PDF
Copyright ©2013 Weppelmann et al; licensee BioMed Central Ltd.
Received Day: 14 Month: 11 Year: 2012
Accepted Day: 9 Month: 1 Year: 2013
collection publication date: Year: 2013
Electronic publication date: Day: 24 Month: 1 Year: 2013
Volume: 12First Page: 30 Last Page: 30
PubMed Id: 23347639
ID: 3599341
Publisher Id: 1475-2875-12-30
DOI: 10.1186/1475-2875-12-30

High frequency of the erythroid silent Duffy antigen genotype and lack of Plasmodium vivax infections in Haiti
Thomas A Weppelmann12 Email:
Tamar E Carter345 Email:
Zhongsheng Chen3 Email:
Michael E von Fricken1 Email:
Yves S Victor6 Email:
Alexander Existe7 Email:
Bernard A Okech12 Email:
1Department of Environmental and Global Health, University of Florida, PO Box 100188, Gainesville, FL 32610, USA
2Emerging Pathogens Institute, University of Florida, 2055 Mowry Rd, P.O. Box 100009, Gainesville, FL 32610, USA
3Genetics Institute, University of Florida, 2033 Mowry Rd, PO Box 103610, Gainesville, FL 32610, USA
4Department of Anthropology, University of Florida, 1112 Turlington Hall, PO Box 117305, Gainesville, FL 32611, USA
5Department of Epidemiology, College of Public Health and Health Professions, University of Florida, PO Box 100231, Gainesville, FL 32611, USA
6Blanchard Clinic, Family Health Ministries Haiti, Terre Noire, Port au Prince, Haiti
7National Public Health Laboratory, Ministry of Public Health and Population (MSPP), Delmas 33, Port au Prince, Haiti


Malaria transmission in Haiti is a serious public health concern where approximately 30,000 cases are reported each year with Centers for Disease Control and Prevention (CDC) estimates as high as 200,000 [1]. Over 99% of malaria infections in Haiti are caused by Plasmodium falciparum, with less than 1% of cases reported as Plasmodium malariae infections [2-4]. There are even fewer reports of Plasmodium vivax in Haiti, all of which were only detected by microscopy and none confirmed by polymerase chain reaction (PCR) based methodologies [2,5,6]. Since P. vivax is responsible for 74% of all cases of malaria in Central and South America and up to 94% of cases in Mexico and Central America, the lack of P. vivax infections in Haiti merits further investigation [1,5,7]. Besides geographical isolation, host genetic factors could be another reason for the lack of P. vivax infections in Haiti. A majority of Haitians are descendants of West African populations, who have a high frequency of individuals that do not express the Duffy antigen receptor for chemokines (DARC) on their erythrocytes [8,9]. The absence of the Duffy antigen on erythrocytes has been shown to reduce or completely prevent P. vivax infections [10-14].

The Duffy antigen is a trans-membrane glycoprotein located on red blood cells that contains a N-terminal domain used by P. vivax merozoites to invade and infect erythrocytes [15,16]. There are two co-dominant alleles FYA and FYB that differ by a single nucleotide at amino acid codon 42, where a change from glycine to aspartic acid results in the expression of the Fya or Fyb antigen, respectively [17]. In many African and African-descendent populations the expression of the Duffy antigen is silenced as a result of a single nucleotide polymorphism (SNP) in the GATA box sequence in the DARC gene promoter region in which a cytosine (C) replaces thymine (T) 46 nucleotides before the erythroid cap site [18-20]. This erythroid silent (ES) genotype, encoded by the FYES allele, is responsible for the Duffy negative phenotype expressed by homozygotes that can reach a population frequency of 100% in native West Africans [9,21].

Neither the reason why P. vivax has been so rarely observed in Haitians, nor the prevalence of the erythroid silent Duffy antigen genotype has been investigated in detail. Therefore, this study investigated the frequency of the FYES allele and P. vivax infections in malaria patients. The information obtained from this study will help clarify the status of P. vivax infections in Haiti.

Data collection

Dried blood samples (DBS) were collected by finger prick and blotted on filter paper (FTA cards, Whatman©) in Haiti from May 2010 to August 2012. The samples originated from several clinics including the Blanchard clinic in Port-au-Prince (n = 164), Hinche (n = 7), Cap-Haitien (n = 7), and Jacmel (n = 6) (Figure 1). Samples from patients at the Blanchard clinic included symptomatic individuals as well as those confirmed by rapid test and/or microscopy to have P. falciparum or mixed infections (P. falciparum and P. malariae or P. vivax). Samples from patients at the other three locations were confirmed by microscopy alone. The DBS were transported to the Emerging Pathogens Institute at the University of Florida and archived in dry storage before further genetic analyses as described below.

DNA extraction

A methanol extraction procedure was used to extract the DNA from the DBS [22]. Three millimetre discs were punched from the DBS, placed inside a PCR tube, and 100 μl of absolute methanol was added. The samples were incubated at 25 degrees Celsius (°C) for 15 minutes, the methanol was removed, and the samples were allowed to dry overnight. Once dry, 65 μl of nuclease free water was added and heated to 95°C for 30 minutes. The samples were centrifuged and then stored at 4°C for immediate use or stored at – 20°C for future use.

Detection of P. vivax by polymerase chain reaction

A species-specific PCR protocol was used to detect the presence of P. vivax in the samples. PCR primers were targeted to detect the P. vivax small subunit ribosomal RNA gene and were able to detect low levels of parasites [23]. The forward primer and reverse primer sequences used were 5 GCAACGCTTCTAGCTTAATC 3 and 5ACAAGGACTTCCAAGCCGAAGC 3, respectively. The PCR temperature protocol was as follows: 94°C for 5 minutes; 94°C for 30 seconds, 58°C for 30 seconds, and 72°C for 60 seconds for 40 cycles; and 72°C for 10 minutes. The expected size of the amplicon was 131 base pairs (bps). All PCR runs included a P. vivax positive control obtained from the malaria reagents and resources center (MR4).

PCR and sequencing of the DARC Gene

A PCR protocol was used to amplify a segment of the DARC gene that was 329 bps and included the –46 T/C SNP [14]. The forward primer and reverse primer sequences used were 5CAGGAAGACCCAAGGCCAG 3 and 5CCATGGCACCGTTTGGTTCAGG 3 respectively. The PCR temperature protocol was as follows: 94°C for 5 min; 94°C for 20 seconds, 62°C for 15 seconds, and 72°C for 20 seconds for 35 cycles; and 72°C for 10 minutes.

Ten of the samples from the malaria patients along with a blood sample from one of the authors of European ancestry were sequenced for the GATA box mutation with the forward and reverse primers described above to identify –46 T and –46C controls for use in the restriction enzyme digestion of patient samples. DNA was sequenced by the Interdisciplinary Center for Biotechnology Research at the University of Florida using Sanger sequencing. Sequence analysis was accomplished by the examination of the chromatograms with 4Peaks (Mekentosj, Amsterdam, NL) software followed by alignments using Clustal X2 [24].

Restriction fragment length polymorphism of DARC

Restriction fragment length polymorphism (RFLP) analysis was used to confirm the presence or absence of the −46 T/C SNP [14]. The PCR products were digested overnight with the restriction endonuclease Sty I (New England Biolabs, Ipswich, MA) according to the manufacturer’s specifications. After heat inactivation of the enzyme for 10 minutes at 65°C, the fragments were stained with ethidium bromide and resolved by gel electrophoresis on a 4% agarose gel for 2.5 hours at 140 volts.


The results from the GATA box mutation analysis and the detection of P. vivax from the DBS are shown below (Table 1). No cases of P. vivax were detected by PCR in 136 patient samples tested from the Blanchard clinic. Of the samples tested for the FYES allele from the same clinic, 99.4% (163/164) had the FYES allele. Of the matched samples (n =99) tested for both the presence of P. vivax and the FYES allele, no P. vivax infections were found and 99% (98/99) had the FYES allele. The remaining samples from the other sites were not tested (NT) for P. vivax, however 100% (20/20) were positive for the FYES allele.


This preliminary study is the first in Haiti to focus on the prevalence of the FYES allele and P. vivax infections in malaria patients. No P. vivax infections were found and 99% of the malaria patients had the FYES allele. The frequency of the FYES allele observed in this study could explain the different rates of P. vivax Haiti as compared to Central and South America, where the majority of infections are P. vivax and the population frequency of the FYES allele is rare [17,25]. The results from this study are similar to other studies conducted in West African populations, who have between 95-100% prevalence of the FYES allele and almost complete absence of P. vivax infections. In a related study in Gambia (n = 1,176) where the population had complete penetrance of the Duffy negative phenotype, of the samples positive for the presence of malaria parasites, 94.8% contained P. falciparum, 3.7% contained P. malariae, 1.5% contained Plasmodium ovale, and 0% contained P. vivax[21]. In another study from nine countries in West and Central Africa (n = 2,588) where the Duffy negative genotype is estimated to be above 95%, PCR analysis of blood samples indicated that of samples positive for malaria parasites, only a single case of P. vivax was found while 98.5% contained P. falciparum, 8.5% contained P. malariae, and 3.9% contained P. ovale[9].

The high frequency of the FYES allele found in this study could be attributed to the West African ancestry of Haitians. Historical records dating back to the 1780s indicate that a large proportion of West Africans brought to the New World during the trans-Atlantic slave trade arrived in Haiti [8]. It is estimated that over 75% of the total number of enslaved Africans in Haiti came from West and West Central Africa, which have almost exclusively the FYES/FYES genotype [8,9]. This study found only a single patient without the FYES allele that may be due to the small proportion of Haitians having French and/or Spanish ancestry or a foreign aid worker, who have much lower population frequencies of the FYES allele [18]. Though the French and the Spanish originally colonized Haiti, in 1804 the French departed and the remaining Spanish sequestered themselves eastward to the Dominican Republic. This massive gene flow from West Africa followed by the establishment of Haiti as an independent country could have contributed to high population frequency of Duffy negative individuals [8].

Although the sample size was relatively small, no P. vivax DNA was found in any of the patient samples, which is consistent with previous reports of the lack of P. vivax in Haiti [2-4]. It is likely that the high prevalence of the FYES allele that causes the Duffy negative phenotype may be responsible for the lack of P. vivax transmission in Haiti. The samples in this study were obtained from areas that are predominantly of West African ancestry, which are more representative of the ancestry of native Haitians. However, historical reports have indicated P. vivax transmission in communes inhabited by higher proportions of people who are of African/European descent that have lower population frequencies of the Duffy negative phenotype [26]. Since P. vivax infections have received little attention, it is unknown if such transmission is still occurring in those areas of Haiti. It is likely that low rates of travelers to Haiti from the surrounding P. vivax endemic countries in South America may have slowed any potential introductions of P. vivax infections into Haiti. Even if introductions were to occur, it would not be likely that P. vivax transmission could be sustained because of the high rates of the FYES allele in the population. A more extensive study with a larger sample size from multiple sites in Haiti is desirable to confirm these results.

In conclusion, no P. vivax infections were confirmed by PCR and the FYES allele that results in silenced expression of the Duffy antigen on erythrocytes was found in 99% of the patients. The high frequency of FYES allele could explain the sparse historical evidence of P. vivax infections in native Haitians and is attributable to their West African ancestry. Though P. vivax malaria is not prevalent and does not represent a significant public health risk in native Haitians, the risk of infection for travellers and foreign aid workers who are Duffy positive remains uncertain.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

TAW carried out the genetic testing for the FYES allele and drafting the manuscript. TC helped conduct the genetic testing for the P. vivax and revision of the manuscript. ZC helped conduct the genetic testing for P. vivax. MEV was involved in drafting of the manuscript. VSF, AE aided in the sample collection. BAO conceived, designed and coordinated the study, and helped draft the manuscript. All authors read and approved the final manuscript.


This study was funded by the Department of Defense-Global Emerging Infections Surveillance grant number #C0607_12_UN to BAO. The authors would like to thank Megan C. Warner for her contributions that ensured the success of this work.

Roberts L,Elimination meets reality in HispaniolaScienceYear: 201032885085110.1126/science.328.5980.85020466921
Lindo JF,Bryce JH,Ducasse MB,Howitt C,Barret DM,Morales JL,Ord R,Burke M,Chiodini PL,Sutherland CJ,Plasmodium malariae in Haitian refugees. JamaicaEmerg Infect DisYear: 20071393193310.3201/eid1306.06122717553241
Agarwal A,McMorrow M,Arguin PM,The increase of imported malaria acquired in Haiti among US travelers in 2010Am J Trop Med HygYear: 20128691010.4269/ajtmh.2012.11-039422232442
PAHORoll back malaria in meso america: report on the meeting held in the dominican republic with the participation of the central american countries (Haiti, and the dominican republic).Year: 2000Mexico: Pan American Health Organization
PAHORegional strategic plan for malaria in the Americas 2006–2010Year: 2010USA: Pan American Health Organization185
PAHOXVIII Pan american sanitary conference XXII regional committee meetingYear: 1970Washington, DC: World Health Organization
Mueller I,Galinski MR,Baird JK,Carlton JM,Kochar DK,Alonso PL,del Portillo HA,Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasiteLancet Infect DisYear: 2009955556610.1016/S1473-3099(09)70177-X19695492
Falola T,Roberts K,Childs M,The yoruba diaspora in the atlantic worldYear: 2004Bloomington, IN: Indiana University Press
Culleton RL,Mita T,Ndounga M,Unger H,Cravo PV,Paganotti GM,Takahashi N,Kaneko A,Eto H,Tinto H,Karema C,D’Alessandro U,do Rosario V,Kobayakawa T,Ntoumi F,Carter R,Tanabe K,Failure to detect plasmodium vivax in west and central africa by PCR species typingMalar JYear: 2008717410.1186/1475-2875-7-17418783630
Zimmerman PA,Woolley I,Masinde GL,Miller SM,McNamara DT,Hazlett F,Mgone CS,Alpers MP,Genton B,Boatin BA,Kazura JW,Emergence of FY*Anull in a Plasmodium vivax-endemic region of Papua New GuineaProc Natl Acad Sci USAYear: 199996139731397710.1073/pnas.96.24.1397310570183
Chaudhuri A,Polyakova J,Zbrzezna V,Pogo AO,The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malaria parasite specificities, and expression in nonerythroid tissues in Duffy-negative individualsBloodYear: 1995856156217833466
Chaudhuri A,Polyakova J,Zbrzezna V,Williams K,Gulati S,Pogo AO,Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasiteProc Natl Acad Sci USAYear: 199390107931079710.1073/pnas.90.22.107938248172
Grimberg BT,Udomsangpetch R,Xainli J,McHenry A,Panichakul T,Sattabongkot J,Cui L,Bockarie M,Chitnis C,Adams J,Zimmerman PA,King CL,Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding proteinPLoS MedYear: 20074e33710.1371/journal.pmed.004033718092885
Kasehagen LJ,Mueller I,Kiniboro B,Bockarie MJ,Reeder JC,Kazura JW,Kastens W,McNamara DT,King CH,Whalen CC,Zimmerman PA,Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotesPLoS OneYear: 20072e33610.1371/journal.pone.000033617389925
VanBuskirk KM,Sevova E,Adams JH,Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognitionProc Natl Acad Sci USAYear: 2004101157541575910.1073/pnas.040542110115498870
Michon P,Stevens JR,Kaneko O,Adams JH,Evolutionary relationships of conserved cysteine-rich motifs in adhesive molecules of malaria parasitesMol Biol EvolYear: 2002191128114210.1093/oxfordjournals.molbev.a00417112082132
King CL,Adams JH,Xianli J,Grimberg BT,McHenry AM,Greenberg LJ,Siddiqui A,Howes RE,da Silva-Nunes M,Ferreira MU,Zimmerman PA,Fya/Fyb antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malariaProc Natl Acad Sci USAYear: 2011108201132011810.1073/pnas.110962110822123959
Tournamille C,Colin Y,Cartron JP,Le Van Kim C,Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negatie individualsNat GenetYear: 19951022422810.1038/ng0695-2247663520
Cavasini CE,de Mattos LC,D’Almedia Couto AAR,D’Almedia Couto VSC,Gollino Y,Moretti LJ,Bonini-Domingos CR,Rossit ARB,Castilho L,Machado RLD,Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon regionMalar JYear: 2007616710.1186/1475-2875-6-16718093292
Castilho L,Rios M,Pellegrino J,Saad STO,Costa FF,Reid ME,A novel FY allele in BraziliansVox SangYear: 20048719019510.1111/j.1423-0410.2004.00554.x15569072
Welch SG,McGregor IA,Williams K,The duffy blood group and malaria prevalence in gambian west AfricansTrans R Soc Trop Med HygYear: 19777129529610.1016/0035-9203(77)90102-X339418
Bereczky S,Martensson A,Gil JP,Farnert A,Short report: rapid DNA extraction from archive blood spots on filter paper for genotyping of Plasmodium falciparumAmJTrop Med HygYear: 200572249251
Hang VT,Screening donor blood for malaria by polymerase chain reactionTrans R Soc Trop Med HygYear: 199559124128
Thompson JD,Gibson TJ,Plewniak F,Jeanmougin F,Higgins DG,The CLUSTAL X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis toolsNucleic Acids ResYear: 1997254876488210.1093/nar/25.24.48769396791
Guerra CA,Snow RW,Hay SI,Mapping the global extent of malaria in 2005Trends ParasitolYear: 20062235335810.1016/
Mason J,Development of the Haiti malaria eradication programme, World Health Organization technical documentYear: 1968WHO/Mal/68.665


[Figure ID: F1]
Figure 1 

Map of Haiti with clinical origin of dried blood spots.

[TableWrap ID: T1] Table 1 

Prevalence of GATA box mutations and P. vivax Infections

Site of sample
(FYES) allele presence
P. vivax presence
Collection No. tested No. positive % Positive No. tested No. positive
Blanchard Clinic
Total 184 99.5% 99.5% 136 0

*NT represents samples not tested for the presence of P. vivax.

Article Categories:
  • Research

Keywords: Plasmodium vivax, Malaria, Hispaniola, Haiti, Duffy antigen receptor for chemokines (DARC), Duffy negative, Genetic susceptibility.

Previous Document:  Preclinical evaluation of sunitinib as a single agent in the prophylactic setting in a mouse model o...
Next Document:  A cross-sectional study on biosecurity practices and communication networks of poultry exhibition in...